301 related articles for article (PubMed ID: 87966)
1. Reduction of pituitary-tumour size in patients with prolactinomas and acromegaly treated with bromocriptine with or without radiotherapy.
Wass JA; Moult PJ; Thorner MO; Dacie JE; Charlesworth M; Jones AE; Besser GM
Lancet; 1979 Jul; 2(8133):66-9. PubMed ID: 87966
[TBL] [Abstract][Full Text] [Related]
2. Additional antitumoral effects of bromocriptine and radiotherapy in patients with prolactinomas or acromegaly.
Coculescu M; Alessandrescu D; Stoica T; Simionescu N; Dimitriu V; Oprescu M; Chelmu S; Urba-Navicius V; Isbăşoiu O
Endocrinologie; 1980; 18(4):277-88. PubMed ID: 7209360
[TBL] [Abstract][Full Text] [Related]
3. The long-term effects of megavoltage radiotherapy as sole or combined therapy for large prolactinomas: studies with high definition computerized tomography.
Johnston DG; Hall K; Kendall-Taylor P; Ross WM; Crombie AL; Cook DB; Watson MJ
Clin Endocrinol (Oxf); 1986 Jun; 24(6):675-85. PubMed ID: 3098457
[TBL] [Abstract][Full Text] [Related]
4. Management of extra-sellar pituitary tumours with bromocriptine: comparison of prolactin secreting and non-functioning tumours using half-field visual evoked potentials and computerised tomography.
Pullan PT; Carroll WM; Chakera TM; Khangure MS; Vaughan RJ
Aust N Z J Med; 1985 Apr; 15(2):203-8. PubMed ID: 3861164
[TBL] [Abstract][Full Text] [Related]
5. Effects of bromocriptine on pituitary tumour size.
McGregor AM; Scanlon MF; Hall R; Hall K
Br Med J; 1979 Sep; 2(6192):700-3. PubMed ID: 509071
[TBL] [Abstract][Full Text] [Related]
6. DNA synthesis by pituitary tumours, with reference to plasma hormone levels and to effects of bromocriptine.
Lloyd HM; Jacobi JM; Willgoss DA
Clin Endocrinol (Oxf); 1995 Jul; 43(1):79-85. PubMed ID: 7641414
[TBL] [Abstract][Full Text] [Related]
7. Parenteral bromocriptine in the treatment of hormonally active pituitary tumours.
Benker G; Gieshoff B; Freundlieb O; Windeck R; Schulte HM; Lancranjan I; Reinwein D
Clin Endocrinol (Oxf); 1986 May; 24(5):505-13. PubMed ID: 3791649
[TBL] [Abstract][Full Text] [Related]
8. Depot-bromocriptine treatment for prolactinomas and acromegaly.
Grossman A; Ross R; Wass JA; Besser GM
Clin Endocrinol (Oxf); 1986 Feb; 24(2):231-8. PubMed ID: 3708874
[TBL] [Abstract][Full Text] [Related]
9. Invasive mixed growth hormone/prolactin secreting pituitary tumour: complete shrinking by octreotide and bromocriptine, and lack of tumour growth relapse 20 months after octreotide withdrawal.
Sadoul JL; Thyss A; Freychet P
Acta Endocrinol (Copenh); 1992 Feb; 126(2):179-83. PubMed ID: 1543025
[TBL] [Abstract][Full Text] [Related]
10. Dramatic and rapid shrinkage of a massive invasive prolactinoma with bromocriptine: a case report.
Clayton RN; Webb J; Heath DA; Dunn PJ; Rolfe EB; Hockley AD
Clin Endocrinol (Oxf); 1985 May; 22(5):573-81. PubMed ID: 4028456
[TBL] [Abstract][Full Text] [Related]
11. Size reduction of extrasellar pituitary tumors during bromocriptine treatment.
Wollesen F; Andersen T; Karle A
Ann Intern Med; 1982 Mar; 96(3):281-6. PubMed ID: 7059088
[TBL] [Abstract][Full Text] [Related]
12. Bromocriptine treatment of prolactin-secreting pituitary adenomas may restore pituitary function.
Warfield A; Finkel DM; Schatz NJ; Savino PJ; Snyder PJ
Ann Intern Med; 1984 Dec; 101(6):783-5. PubMed ID: 6497193
[TBL] [Abstract][Full Text] [Related]
13. Bromocriptine reduction of prolactinoma size.
Corenblum B; Hanley DA
Fertil Steril; 1981 Dec; 36(6):716-9. PubMed ID: 7308514
[TBL] [Abstract][Full Text] [Related]
14. Morphological changes in bromocriptine-treated pituitary tumours.
Anniko M; Wersäll J
Acta Otolaryngol; 1983; 96(3-4):337-53. PubMed ID: 6637451
[TBL] [Abstract][Full Text] [Related]
15. Prolactinomas presenting as primary amenorrhoea and delayed or arrested puberty: response to medical therapy.
Howlett TA; Wass JA; Grossman A; Plowman PN; Charlesworth M; Touzel R; Rees LH; Savage MO; Besser GM
Clin Endocrinol (Oxf); 1989 Feb; 30(2):131-40. PubMed ID: 2612015
[TBL] [Abstract][Full Text] [Related]
16. Failure of bromocriptine to maintain reduction in size of a macroprolactinoma.
Breidahl HD; Topliss DJ; Pike JW
Br Med J (Clin Res Ed); 1983 Aug; 287(6390):451-2. PubMed ID: 6411170
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy after bromocriptine-induced reduction of an extrasellar prolactin-secreting pituitary macroadenoma.
Goodman LA; Chang RJ
Obstet Gynecol; 1984 Sep; 64(3 Suppl):2S-7S. PubMed ID: 6433250
[TBL] [Abstract][Full Text] [Related]
18. Effect of bromocriptine on DNA synthesis, growth and hormone secretion of spontaneous pituitary tumours in the rat.
Prysor-Jones RA; Jenkins JS
J Endocrinol; 1981 Mar; 88(3):463-9. PubMed ID: 7217831
[TBL] [Abstract][Full Text] [Related]
19. Rapid resolution of visual abnormalities with medical therapy alone in patients with large prolactinomas.
Mbanya JC; Mendelow AD; Crawford PJ; Hall K; Dewar JH; Kendall-Taylor P
Br J Neurosurg; 1993; 7(5):519-27. PubMed ID: 8267889
[TBL] [Abstract][Full Text] [Related]
20. Conservative management of pituitary prolactinomas; evidence for bromocriptine-induced regression.
Hancock KW; Scott JS; Lamb JT; Gibson RM; Chapman C
Br J Obstet Gynaecol; 1980 Jun; 87(6):523-9. PubMed ID: 7397087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
